EUVIMEDEUVIMED entdecken
Crossref

In Vitro Activity of Ceftazidime/Avibactam Against Multidrug-Resistant Gram-Negative Bacilli in Niger

Issoufou Noma Massir, Abdourahamane Yacouba, Ounoussa Tapha, Harouna Moussa, Abdoulaye Ousmane, Souleymane Brah, Mahamadou Doutchi, Laminou Maman Ibrahim

NMJ · 17.09.2025

DOI: 10.71480/nmj.v67i3.1057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMJ, erschienen am 17.09.2025. Verfasst von Issoufou Noma Massir und 7 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rise of multidrug-resistant Gram-negative bacilli (MDR-GNB) necessitates the evaluation of new antibiotics such as ceftazidime-avibactam (CZA). Data on its efficacy in Niger is scarce. This study assessed the in vitro activity of CZA against clinical MDR-GNB isolates. Methodology: This prospective cross-sectional study was carried out on 306 non-duplicate MDR-GNB isolates from a National Reference Laboratory from December 2023 to November 2024. Antimicrobial susceptibility testing was performed, and CZA resistance rates were determined. Statistical analysis identified factors associated with resistance.

Results

Overall, 23.4% of MDR isolates were resistant to CZA. However, resistance varied dramatically by phenotype: 7.6% in ESBL-producing Enterobacterales (ESBL-E), 33.3% in carbapenem-resistant Pseudomonas aeruginosa (CRPA), 61.7% in carbapenem-resistant Enterobacterales (CRE), and 100% in carbapenem-resistant Acinetobacter baumannii (CRAB). Multivariate analysis confirmed that carbapenem resistance was the strongest predictor of CZA resistance (OR=19.00, 95% CI: 9.96-38.27, p

Schlagwörter

ceftazidime-avibactammultidrug-resistant Gram-negative bacteriacarbapenem resistancecarbapenem-resistant Pseudomonas aeruginosaantimicrobial susceptibilityresistance determinantsantimicrobial stewardshipNiger

Zitieren

APA

Massir, I. N., Yacouba, A., Tapha, O., Moussa, H., Ousmane, A., Brah, S., Doutchi, M., & Ibrahim, L. M. (2025). In Vitro Activity of Ceftazidime/Avibactam Against Multidrug-Resistant Gram-Negative Bacilli in Niger. NMJ. https://doi.org/10.71480/nmj.v67i3.1057

Vancouver

Massir IN, Yacouba A, Tapha O, Moussa H, Ousmane A, Brah S, et al. In Vitro Activity of Ceftazidime/Avibactam Against Multidrug-Resistant Gram-Negative Bacilli in Niger. NMJ. 2025. doi:10.71480/nmj.v67i3.1057

BibTeX
@article{Massir2025,
  author = {Massir, Issoufou Noma and Yacouba, Abdourahamane and Tapha, Ounoussa and Moussa, Harouna and Ousmane, Abdoulaye and Brah, Souleymane and Doutchi, Mahamadou and Ibrahim, Laminou Maman},
  title = {In Vitro Activity of Ceftazidime/Avibactam Against Multidrug-Resistant Gram-Negative Bacilli in Niger},
  journal = {NMJ},
  year = {2025},
  doi = {10.71480/nmj.v67i3.1057}
}
Kostenlos starten →